Primary Care

Addiction Medicine

Questions discussed in this category

Do you start more than one medication for alcohol use disorder simultaneously (e.g., disulfram with gabapentin, acamprosate, or naltrexone) or do you start one agent at a time?

1 Answer available

What is your medication of choice when considering outpatient alcohol withdrawal management (diazepam vs chlordiazepoxide vs lorazepam)?

For your recommended medication, are you doing a scheduled set dose, or is it primarily symptom-driven?

4 Answers available

What is your preferred first line management of alcohol use disorder with concomitant depression?

2 Answers available

For those who don't have access to addiction medicine, have you considered using naltrexone for the treatment of stimulant use disorder in your primary care clinic?

What medical co-morbid conditions are most helpful when trying to decide which agent to start with?

2 Answers available

When (if ever) do you recommend taping a patient off of buprenorphine after sustained remission?

If so, you have a recommended tapering strategy?

1 Answer available

Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?

2 Answers available

Papers discussed in this category

Drug and alcohol dependence, 2024 Sep 07

Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.

JAMA psychiatry, 2025 Apr 01

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.

Journal of addiction medicine, 2020 May/Jun

The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management.

Alcohol (Fayetteville, N.Y.), 2014-06

The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS): systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome.

American journal of preventive medicine, 2015-10

Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines.

Journal of addiction medicine, 2021 May-Jun 01

Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series.

Related Topics in Primary Care